Written by Klarity Editorial Team
Published: Jul 13, 2026

Last updated: July 13, 2026
If you have Humana health insurance in New Mexico and you or a family member needs ADHD evaluation or treatment, this guide explains exactly how your Medicare Advantage coverage works in 2026 — including which ADHD medications are covered under Humana Pharmacy Solutions (HPS), when prior authorization is required, how electronic prescribing rules apply to stimulant medications, and how to navigate your benefits. See if Klarity’s licensed ADHD providers may be a fit for your Humana plan.
Before diving into ADHD coverage details, there is a critical fact every New Mexico Humana member should understand: Humana exited the commercial (employer-sponsored and individual marketplace) insurance market in 2024. In New Mexico in 2026, Humana offers Medicare Advantage (MA) plans only — plan types include Gold Plus HMO, HumanaChoice PPO, and related Medicare Advantage Prescription Drug (MAPD) products.
This means Humana coverage for ADHD treatment in New Mexico applies specifically to Medicare Advantage members — adults 65 and older, or adults under 65 who qualify for Medicare through disability. If you have Humana through an employer, a marketplace plan, or a Medicaid-linked program, you likely have a different insurer managing your benefits. Contact your HR department or the New Mexico Human Services Department to confirm your plan type.
Medicaid disclaimer: Humana Medicare Advantage plans are not Medicaid. If you have both Medicare and Medicaid, you may qualify for a Humana Dual Eligible Special Needs Plan (D-SNP), which coordinates benefits across both programs. D-SNP coverage terms differ from standard MAPD — contact Humana at 1-800-448-6262 to confirm your specific plan’s ADHD benefits.
Medicare Advantage plans must comply with the Mental Health Parity and Addiction Equity Act (MHPAEA) as administered through federal Medicare Advantage regulations — specifically CMS 42 CFR Part 422. Under this framework, Humana MA plans are required to apply the same financial requirements and treatment limitations to mental health and substance use disorder benefits (including ADHD) as they apply to comparable medical/surgical benefits.
This federal parity mandate — enforced by the Centers for Medicare and Medicaid Services (CMS) — governs Humana’s ADHD coverage obligations in New Mexico. Note that New Mexico’s state parity law, NMSA 1978 § 59A-23E-19 et seq., applies to state-regulated commercial insurance plans. Because Humana NM operates exclusively under Medicare Advantage — a federally regulated product — the federal CMS framework (42 CFR Part 422) is the governing parity authority, not the state statute.
In practical terms, Humana Medicare Advantage plans in New Mexico typically cover:
Coverage may vary by specific plan tier, county, and enrollment year. Always verify your specific benefits before scheduling a visit.
Prescription drug coverage for Humana Medicare Advantage members in New Mexico is managed through Humana Pharmacy Solutions (HPS), Humana’s integrated pharmacy benefit manager. ADHD medications fall into two categories on the HPS formulary: stimulants and non-stimulants.
| Medication | Type | HPS Tier | Prior Auth Required |
|---|---|---|---|
| Amphetamine salts (Adderall generic) | Stimulant — Schedule II | Tier 1–2 | No (generic preferred) |
| Amphetamine ER (Adderall XR generic) | Stimulant — Schedule II | Tier 1–2 | No (generic preferred) |
| Methylphenidate (Ritalin generic) | Stimulant — Schedule II | Tier 1–2 | No (generic preferred) |
| Methylphenidate ER (Concerta generic) | Stimulant — Schedule II | Tier 1–2 | No (generic preferred) |
| Lisdexamfetamine (Vyvanse / generic) | Stimulant — Schedule II | Tier 3–4 | Yes — step therapy typically required |
| Adderall XR (brand) | Stimulant — Schedule II | Tier 3–4 | Yes — brand requires PA + step therapy |
| Concerta (brand) | Stimulant — Schedule II | Tier 3–4 | Yes — brand requires PA + step therapy |
| Dexmethylphenidate (Focalin / Focalin XR) | Stimulant — Schedule II | Tier 2–3 | Verify with plan |
Note on generic lisdexamfetamine: Generic lisdexamfetamine (previously only available as brand Vyvanse) became available in 2023. HPS tier placement for generic lisdexamfetamine may differ from brand Vyvanse. Verify current tier and PA requirements with HPS at 1-800-379-0092 before prescribing or filling, as formularies can change during the plan year.
| Medication | Type | HPS Tier | Prior Auth Required |
|---|---|---|---|
| Atomoxetine (Strattera generic) | Non-stimulant — non-scheduled | Tier 1–2 | No (generic preferred) |
| Guanfacine ER (Intuniv generic) | Non-stimulant — non-scheduled | Tier 1–2 | No |
| Clonidine ER (Kapvay generic) | Non-stimulant — non-scheduled | Tier 1–2 | No |
| Viloxazine (Qelbree) | Non-stimulant — non-scheduled | Tier 3–4 | Yes — PA typically required |
| Bupropion (off-label ADHD) | Non-stimulant — non-scheduled | Tier 1–2 | No (generic) |
Non-stimulant medications are not Schedule II controlled substances, so they are not subject to the electronic prescribing requirements described below.
Because most ADHD stimulant medications are Schedule II controlled substances under the DEA Controlled Substances Act, they are subject to the federal Electronic Prescribing for Controlled Substances (EPCS) requirements under 21 CFR Part 1311.
Under EPCS rules, prescribers must transmit Schedule II stimulant prescriptions electronically using DEA-compliant e-prescribing software with two-factor authentication. Paper prescriptions for Schedule II stimulants are no longer permitted in most circumstances under federal telehealth prescribing regulations. New Mexico has also aligned its state pharmacy rules with these federal requirements.
What this means for your ADHD appointment: Your Klarity provider will issue your stimulant prescription electronically, transmitted directly to your chosen pharmacy. You do not need to pick up a paper prescription. Your pharmacy receives the order securely through the EPCS system, and you can fill it immediately upon approval.
EPCS applies specifically to Schedule II controlled substances. Non-stimulant ADHD medications (atomoxetine, guanfacine, clonidine, viloxazine, bupropion) are not Schedule II and are not subject to EPCS requirements.
Many brand-name and specialty ADHD medications on the HPS formulary require prior authorization (PA) before Humana will cover them. PA for ADHD medications under Humana Medicare Advantage typically involves:
If your PA request is denied, Humana Medicare Advantage members have appeal rights under CMS guidelines. You may file a coverage determination request, a redetermination (Level 1 appeal), and escalate to an Independent Review Entity (IRE) if the redetermination is unfavorable. Contact Humana at 1-800-448-6262 for appeal assistance.
Like many Medicare Advantage plans, Humana separates its medical benefit administration from its pharmacy benefit management. Understanding which department to contact can save significant time:
For ADHD treatment specifically: if your question is about a prescription drug (which tier, whether PA is needed, how to submit a pharmacy PA), contact HPS at 1-800-379-0092. If your question is about a behavioral health visit (whether a telehealth ADHD appointment is covered, what your copay is, how to appeal a visit denial), contact Humana Member Services at 1-800-448-6262 or the behavioral health line at 1-877-693-5236.
Klarity Health connects patients with 2,000+ licensed providers across the United States who specialize in ADHD evaluation, diagnosis, and medication management. Many of Klarity’s providers are licensed in New Mexico and conduct appointments via telehealth.
Medicare Advantage telehealth coverage has expanded significantly since 2020, and CMS has made several telehealth flexibilities permanent for MA plans. Humana Medicare Advantage members in New Mexico may have telehealth benefits for mental health and behavioral health visits, including ADHD management, subject to their specific plan’s telehealth terms.
Key points for Humana MA members considering Klarity:
Check if Klarity’s ADHD providers may be in-network for your Humana Medicare Advantage plan.
Humana Medicare Advantage plans in New Mexico typically cover ADHD evaluation and diagnosis as an outpatient behavioral health benefit, subject to your plan’s copay and deductible structure. Coverage may vary by plan type (HMO vs. PPO) and whether the provider is in-network. Verify your specific benefits at 1-800-448-6262 before scheduling.
Generic amphetamine salts (Adderall generic) are typically on the HPS formulary at Tier 1–2 without prior authorization for Medicare Advantage members. Brand Adderall XR is typically Tier 3–4 and may require PA and step therapy documentation showing generic was tried first. EPCS electronic prescribing applies since Adderall is Schedule II.
Lisdexamfetamine (Vyvanse) — both brand and generic — is typically Tier 3–4 on the HPS formulary and usually requires prior authorization with step therapy documentation. Generic lisdexamfetamine may be at a lower tier; verify with HPS at 1-800-379-0092 as tier placement can change during the plan year. EPCS electronic prescribing applies.
Humana Medicare Advantage plans in New Mexico are governed by federal Medicare Advantage parity rules under CMS 42 CFR Part 422 and the MHPAEA, administered by CMS. New Mexico’s state parity statute (NMSA 1978 § 59A-23E-19) applies to state-regulated commercial insurance — not to Medicare Advantage plans, which are federally regulated. CMS enforces parity compliance for MA plans. If you believe Humana is imposing stricter limits on ADHD benefits than on comparable medical benefits, you may file a complaint with CMS at 1-800-633-4227 or with NM OSI at 1-855-427-5674.
If you have Humana through a Medicaid-linked program (such as Humana’s D-SNP dual-eligible plan), your ADHD coverage terms may differ from standard Medicare Advantage. Dual-eligible plans coordinate Medicare and Medicaid benefits. Contact Humana at 1-800-448-6262 and identify yourself as a Medicaid or D-SNP member for accurate benefit information specific to your plan.
Humana Medicare Advantage plans have expanded telehealth benefits, and many behavioral health services — including ADHD medication management — may be available via telehealth. CMS has made several telehealth flexibilities permanent for MA plans. Verify your plan’s telehealth terms at 1-800-448-6262, and check whether your Klarity provider is in-network or whether out-of-network telehealth benefits apply.
Disclaimer: This article is for informational purposes only and does not constitute insurance advice. Coverage terms, formulary tiers, and prior authorization requirements may vary by specific Humana Medicare Advantage plan, plan year, and individual member circumstances. Always verify your benefits directly with Humana at 1-800-448-6262 or HPS at 1-800-379-0092 before scheduling an appointment or filling a prescription. Use of the word “may” throughout this guide reflects genuine uncertainty — coverage is not guaranteed and must be verified with your plan. Klarity Health does not guarantee insurance reimbursement.
Find the right provider for your needs — select your state to find expert care near you.